Saturday, July 2018
Now Reading:
ZCL Chemicals Ltd.
Full Article 3 minutes read

zclZCL Chemicals Ltd (formerly Zandu Chemicals Ltd.) is one of the fastest growing Pharmaceutical companies in India. Established in 1991, it is headquartered in Mumbai and have a state-of-the-art US FDA successfully inspected facility with a capacity of 214 KL along with strong research and development capabilities strategically located in the industrial park of Ankleshwar, Gujarat. ZCL Chemicals ltd is a 100% EOU (Export Oriented Unit) engaged in manufacturing and exports of advanced drug intermediates and Active Pharma Ingredients (APIs).
It is a specialized pharma company focusing on niche therapeutic areas of CNS, ARVs and controlled substances. Its specialization in unique CNS segments like ADHD, Anti-psychotics, Anti-vertigo, Antiinflammatory, Pain management, Alzheimer disease and others gives ZCL the leverage to outclass the competition. By virtue of this niche focus the company has registered an impressive growth over the years.
Its strategy going forward is to further consolidate the pre-eminent position in the high growth therapeutic areas by expanding its capacity for present advanced intermediates and moving up the value chain by expanding capacity for APIs and diversifying product portfolio into the other high growth therapeutic areas like anti-diabetic, anti-coagulants, and others.zcl-image
It is a US FDA, KFDA, WHO-GMP and Japanese MOH accredited company having certifications of ISO 9001, ISO 14001 and OHSAS 18001. It enjoys the CRISIL rating of A(-) and have SAP system in place.

# Key Features
Highly customer-centric and has been a preferred partner to some of the global innovator and generic pharma companies
Focused in Central Nervous System and global leaders in Methylphenidate family of intermediates and Darunavir family of intermediates
96% of revenue from exports especially to North America and Europe and Japan (Regulated Markets).
Embarked on a major expansion plan

While over 90% of its revenue is from established markets, the company is also growing rapidly in the emerging markets. It has an established track record in pharma business with focus on low to medium volume and high value products.
The company has spent years creating a culture around the customer and their needs. Its customer-centric approach has won the status of a preferred supplier/strategic partner from global pharmaceutical innovators and generic companies. It has aligned the entire organization to be decisive and agile that keeps it winning its customers’ appreciation.
With the best in class manufacturing facilities with accreditation and stateof- the-art research platform besides brilliant minds in our R&D the company has embarked on establishing contract manufacturing organization. It has many on-going contract manufacturing projects that involve complex chemistry and technological excellence.
The company’s current business focuses on three major business segments i.e., Active Pharmaceuticals Ingredients (APIs);Advanced Intermediates and Contract Manufacturing of APIs and Intermediates (with or without technology transfers). The commitment is to keep up the tradition of delivering customer value and having its valuable customers in the very heart of the corporate focus.

Input your search keywords and press Enter.